
How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.
Essentra has signed an agreement to acquire Clondalkin's Specialist Packaging Division for a cash consideration of approximately $455 million.
Essentra has signed an agreement to acquire Clondalkin’s Specialist Packaging Division for a cash consideration of approximately $455 million. According to the press release, the transaction marks Essentra’s largest acquisition to date and is expected to complete in the first quarter of 2015.
Clondalkin SPD is a global provider of speciality secondary packaging solutions for the pharmaceutical and health and personal care industries, with 24 facilities. It is believed that the acquisition will add to Essentra’s position in these markets.
Source:





